Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rima McLeod

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 13, 2008
Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapyJoseph D Benevento, Rama D Jager, A Gwendolyn Noble, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2006
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis StudyRima McLeod, Kenneth Boyer, Theodore Karrison, et al.
International Journal for Parasitology|March 9, 2004
Evidence for mitochondrial-derived alternative oxidase in the apicomplexan parasite Cryptosporidium parvum: a potential anti-microbial agent targetCraig W Roberts, Fiona Roberts, Fiona L Henriquez, et al.
Elife|January 30, 2016
Toxoplasma gondii peptide ligands open the gate of the HLA class I binding grooveCurtis McMurtrey, Thomas Trolle, Tiffany Sansom, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptidesStephen P Muench, Jozef Stec, Ying Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|January 9, 2014
The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme targetCraig Wilkinson, Martin J McPhillie, Ying Zhou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2011
Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North AmericaKenneth Boyer, Dolores Hill, Ernest Mui, et al.
Plos One|December 3, 2010
T. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrestSamuel L Hutson, Ernest Mui, Karen Kinsley, et al.
Ecohealth|June 7, 2019
Correction to: The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention StrategiesA Alonso Aguirre, Travis Longcore, Michelle Barbieri, et al.
Ecohealth|April 5, 2019
The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention StrategiesA Alonso Aguirre, Travis Longcore, Michelle Barbieri, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 13, 2008
Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapyJoseph D Benevento, Rama D Jager, A Gwendolyn Noble, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2006
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis StudyRima McLeod, Kenneth Boyer, Theodore Karrison, et al.
International Journal for Parasitology|March 9, 2004
Evidence for mitochondrial-derived alternative oxidase in the apicomplexan parasite Cryptosporidium parvum: a potential anti-microbial agent targetCraig W Roberts, Fiona Roberts, Fiona L Henriquez, et al.
Elife|January 30, 2016
Toxoplasma gondii peptide ligands open the gate of the HLA class I binding grooveCurtis McMurtrey, Thomas Trolle, Tiffany Sansom, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptidesStephen P Muench, Jozef Stec, Ying Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|January 9, 2014
The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme targetCraig Wilkinson, Martin J McPhillie, Ying Zhou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2011
Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North AmericaKenneth Boyer, Dolores Hill, Ernest Mui, et al.
Plos One|December 3, 2010
T. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrestSamuel L Hutson, Ernest Mui, Karen Kinsley, et al.
Ecohealth|June 7, 2019
Correction to: The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention StrategiesA Alonso Aguirre, Travis Longcore, Michelle Barbieri, et al.
Ecohealth|April 5, 2019
The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention StrategiesA Alonso Aguirre, Travis Longcore, Michelle Barbieri, et al.
Pageof 11